Sindhu Doppalapudi
Overview
Explore the profile of Sindhu Doppalapudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
840
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doppalapudi S, Jain A, Khan W, Domb A
Int J Pharm
. 2019 Nov;
573:118726.
PMID: 31715365
Fenoldopam, a highly selective dopamine receptor agonist, is available in clinics as Corlopam™ i.v. for the management of severe hypertension. Recent reports demonstrate its anti-proliferative activity in vitro in a...
2.
Walunj M, Doppalapudi S, Bulbake U, Khan W
J Liposome Res
. 2019 Mar;
30(1):68-79.
PMID: 30897993
Cyclosporine (CYC), a calcineurin inhibitor acts specifically on T-cells and is one of the most effective treatment options for psoriasis. Systemic administration of the drug has been associated with dose-dependent...
3.
Doppalapudi S, Mahira S, Khan W
J Photochem Photobiol B
. 2017 Jul;
174:44-57.
PMID: 28753523
Vitiligo is a de-pigmenting skin disorder characterized by white patches on skin due to partial or complete loss of melanocytes. Psoralen in combination with ultraviolet-A (PUVA) acts by stimulation of...
4.
Jain A, Pooladanda V, Bulbake U, Doppalapudi S, Rafeeqi T, Godugu C, et al.
Nanomedicine
. 2017 Jun;
13(7):2251-2262.
PMID: 28647592
Thymoquinone (TMQ) is reported with good anti-psoriatic activity; however, the hydrophobicity, poor aqueous solubility, light and pH sensitive nature of TMQ hinder its delivery to target site. To address these...
5.
Bulbake U, Doppalapudi S, Kommineni N, Khan W
Pharmaceutics
. 2017 Mar;
9(2).
PMID: 28346375
Liposomes are the first nano drug delivery systems that have been successfully translated into real-time clinical applications. These closed bilayer phospholipid vesicles have witnessed many technical advances in recent years...
6.
Jain A, Doppalapudi S, Domb A, Khan W
J Control Release
. 2016 Nov;
243:132-145.
PMID: 27725194
Psoriasis is an autoimmune skin disorder characterized by hyper proliferation and poor differentiation of keratinocytes. It significantly affects patient's quality of life. This study reports the anti-psoriatic efficacy of tacrolimus...
7.
Doppalapudi S, Jain A, Chopra D, Khan W
Eur J Pharm Sci
. 2016 Oct;
96:515-529.
PMID: 27777066
Psoralen in combination with ultraviolet A radiation (PUVA) is an FDA recommended therapy for clinical application in the management of severe recalcitrant psoriasis. Psoralen acts by intercalation of DNA and...
8.
Basu A, Kunduru K, Doppalapudi S, Domb A, Khan W
Adv Drug Deliv Rev
. 2016 Jul;
107:192-205.
PMID: 27432797
Polylactide (PLA) and its copolymers are hydrophobic polyesters used for biomedical applications. Hydrogel medicinal implants have been used as drug delivery vehicles and scaffolds for tissue engineering, tissue augmentation and...
9.
Doppalapudi S, Jain A, Domb A, Khan W
Expert Opin Drug Deliv
. 2016 Mar;
13(6):891-909.
PMID: 26983898
Introduction: Biodegradable polymers have been used for more than three decades in cancer treatment and have received increased interest in recent years. A range of biodegradable polymeric drug delivery systems...